Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. - Wikidata - awgldk - TriplyDB

Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.

Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.

http://www.wikidata.org/entity/Q43052157

about

The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series)Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.New trial designs and potential therapies for pulmonary artery hypertension.Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.Down-regulation of replication factor C-40 (RFC40) causes chromosomal missegregation in neonatal and hypertrophic adult rat cardiac myocytes.Mechanisms of right heart failure-A work in progress and a plea for failure prevention Systems approach to the study of stretch and arrhythmias in right ventricular failure induced in rats by monocrotaline Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.New perspectives for the treatment of pulmonary hypertension Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension The need to recognize the pulmonary circulation and the right ventricle as an integrated functional unit: facts and hypotheses (2013 Grover Conference series).Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series).Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.Diagnosing and treating the failing right heart.Severe pulmonary arterial hypertensive rats are tolerant to mild exercise.Current clinical management of pulmonary arterial hypertension Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.Right ventricular failure due to chronic pressure load: What have we learned in animal models since the NIH working group statement?Heart Rate Variability is Related to Disease Severity in Children and Young Adults with Pulmonary Hypertension.Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.Differential calcium handling in two canine models of right ventricular pressure overload.A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational study Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma.Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure Novel therapeutic approaches to preserve the right ventricle.Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension.Phosphorylation inactivation of endothelial nitric oxide synthesis in pulmonary arterial hypertension.Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril Stiffness.Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.

P2860

Q26781681-5CAA85D0-28D7-4BAB-8379-A39BEC64BA80 Q28083183-7BBD3814-3CC1-44B5-ADD0-F16C5C14D3C0 Q28085007-42B4551C-F274-418A-BF2D-F09219844D75 Q28730633-DFC1A1D4-FB52-43A6-8664-3A7A51C2DA83 Q30544892-0E32AF53-1A3B-4712-B58B-B2D134148A48 Q30585014-ED522006-177E-4C4E-AF97-84366DA88A52 Q31042887-C59A9899-D309-4036-8ADC-AD8E6E2A8E4D Q33764990-DDC212DE-AB24-4DE5-8E40-CAF857B9889F Q33982467-3336C27C-D19D-4996-9E25-F757C89B54AC Q34011572-AB225BBA-0A02-4087-9F66-FC8FE56051CC Q34312069-7A41BE76-044A-43ED-A39D-7B289CD455F5 Q34343977-CCEABF38-FE16-4B67-A784-CF78D38C7EA6 Q34410906-CFCFA784-0B81-49F8-9AC7-1F451B772941 Q34412447-1773AFC7-A836-4811-B4B5-7C299E593FAA Q34782558-6CE81F18-56FE-43B5-8BC9-E7FF13DB367F Q34903204-A258BC66-A0BC-43ED-9CB6-EDFCB793A92F Q35021804-9B68E8D7-565E-4586-A7CC-4213F388F530 Q35040811-EBCAD4ED-7D5B-4BE4-AED1-820E54FCEC55 Q35517479-48A01F93-5E92-4433-960A-C489AD16E479 Q35517542-9D32DE69-BFA8-4BF1-93E2-0E5F36313E37 Q35517559-C91B6073-8587-4E61-871A-388652A2ADF0 Q35574717-5D04FB2D-C6F8-4C21-849D-81203EC94F8E Q35599768-0B09F095-A346-4E69-989C-A8D14953AFD1 Q35665772-7450CFF1-88B8-4442-A4CF-064107A134B1 Q35673783-18098CAB-FEDA-44A8-B788-B30396B059E3 Q35705453-FB8B1B8D-A6D1-42B2-A85C-38AB9C086334 Q35725663-7FBFDF19-7C02-4D0D-BCE3-9C15E82A5B72 Q35824146-90B3932B-5D02-41BF-8836-04D1CC812BF4 Q35991277-CD653189-8254-4ACE-93B7-3D804C9B3A2E Q35991288-17AE1C08-4D48-4D4B-8733-3DEF6A39D939 Q36198962-C27D8E84-856E-46AB-B930-9FA31E4E93F1 Q36376386-5C632F50-90CA-4DA7-9C23-EEC67C2FEE7C Q36468672-A0E17060-53F0-4644-833C-0DFDF206A26C Q36593515-0D3CC64E-B85A-46F1-AE6D-E396DC55167B Q36619235-B4CA0711-B210-436D-A96C-BC0053290E9B Q36923968-07A12F3A-B23E-43C3-A05E-86337FD569E6 Q37071749-499FD076-FDC4-464A-BC43-A7775B3699BA Q37116376-2DE9ACA6-795D-487C-842C-B0D60E5CCF82 Q37216215-4E39A1F7-C06D-409A-9DBB-48B29B7DDA8A Q37575862-AC2A04A7-7995-4286-93CF-1342F573313D

P2860

Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.

http://www.wikidata.org/entity/Q43052157

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Adrenergic receptor blockade r ...... n pulmonary hypertensive rats.

@en

Adrenergic receptor blockade r ...... n pulmonary hypertensive rats.

@nl

type

label

Adrenergic receptor blockade r ...... n pulmonary hypertensive rats.

@en

Adrenergic receptor blockade r ...... n pulmonary hypertensive rats.

@nl

prefLabel

Adrenergic receptor blockade r ...... n pulmonary hypertensive rats.

@en

Adrenergic receptor blockade r ...... n pulmonary hypertensive rats.

@nl

P1433

Q43052157-67FD1AFE-E336-4C2E-B66A-D28F4DA19F2A

P1476

Q43052157-AF61CA8C-EF32-46E7-A88F-C146043E2831

P2093

Q43052157-1DF625E3-49AB-4180-A413-CBA922A509C4

Q43052157-6072BABF-A23F-4535-8751-480F9A163D44

Q43052157-6A7D1D63-88BD-435E-8453-A4B9E7081E42

Q43052157-71C67241-8CD8-4508-BE30-4CAED787432F

Q43052157-7A06AFCF-9C9F-4EBC-8735-4E6CB3BD5C81

Q43052157-9681494B-4F89-43F1-8EB2-FAC3D50FE890

Q43052157-A38070B2-2B7D-4328-ACC0-5898FCD6E207

Q43052157-B312DA1C-50CB-4506-8766-69032854F705

Q43052157-B57F8F57-1603-4834-94D9-69A681AAFEDB

Q43052157-F66BDDB6-C013-435E-960F-01F368EB32B1

P304

Q43052157-BE976DB4-2733-4F53-A2E4-7D4E7B32172E

P31

Q43052157-88CB8E1D-6042-4C28-8A63-636C92763677

P356

Q43052157-7665DD2A-5BFF-4338-ABBA-96FE5DF19E50

P407

Q43052157-7005DA8F-9B36-4D18-B6AC-C852EC65D998

P433

Q43052157-D90FDFE0-E407-444B-BC16-DF5B8941E04A

P478

Q43052157-42EB9C7D-D643-4A9A-AD5F-8B894B026DE0

P50

Q43052157-B16BDD63-0E29-40EA-B7DF-B5086BDE58D1

P577

Q43052157-2917DF52-ED02-4632-A016-85030741D6E1

P5875

Q43052157-FB593B53-02FC-4A5F-A3FA-9379F8E616C1

P698

Q43052157-012ADCBC-9C2A-4E2A-ABA3-6FA0539A1A20

P356

RCCM.201003-0335OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Adrenergic receptor blockade r ...... n pulmonary hypertensive rats.

@en

P2093

Antonio Abbate

http://www.w3.org/2001/XMLSchema#string

Donatas Kraskauskas

http://www.w3.org/2001/XMLSchema#string

Fadi N Salloum

http://www.w3.org/2001/XMLSchema#string

Harm J Bogaard

http://www.w3.org/2001/XMLSchema#string

Michael Kasper

http://www.w3.org/2001/XMLSchema#string

Nicholas N Hoke

http://www.w3.org/2001/XMLSchema#string

Norbert F Voelkel

http://www.w3.org/2001/XMLSchema#string

Philip J Chang

http://www.w3.org/2001/XMLSchema#string

Shiro Mizuno

http://www.w3.org/2001/XMLSchema#string

Vinh Q Chau

http://www.w3.org/2001/XMLSchema#string

P304

652-660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201003-0335OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

Ramesh Natarajan

P577

2010-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44635806

http://www.w3.org/2001/XMLSchema#string

P698

20508210

http://www.w3.org/2001/XMLSchema#string